On the new hires (and from an IV post...)
She came from Cynapsus, bought by Sunovion in 2016. Before that, Sanofi, dealing with the Genzyme merger.
He came from Aralez Pharmaceuticals, who sold off two halves of the business to two different companies. Before that was Astellas Pharma, with a history of acquisitions including 2 in 2016, 2 in 2017, 2 in 2018, 2 in 2019, another in 2020...
Is this indicative of Titan's future?
These folks have great resumes for a company that might be planning to get acquired. Otherwise, their experience is less applicable to a steady-state development company looking to break into a burgeoning market in a year or two. They would be the wrong hires for that scenario.
Message in reply to:
Why would TMDI fill 2 new leadership positions that have merger and divestiture experience now?
Right before the next milestones and AGM
News 
Market Data 
Discover 
